Preoperative hemoglobin-platelet ratio can significantly predict progression and mortality outcomes in patients with T1G3 bladder cancer undergoing transurethral resection of bladder tumor

OBJECTIVE: To investigate the prognostic role of hematological biomarkers, especially hemoglobin-platelet ratio (HPR) in the oncological outcomes in stage 1 and grade 3 (T1G3) bladder cancer. MATERIALS AND METHODS: We identified 457 T1G3 bladder cancer patients who underwent transurethral resection...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Gang, Zhen, Yunpeng, Xie, Wanqin, Wang, Yinlei, Chen, Feiran, Qin, Chuan, Yang, Han, Du, Zhiyong, Shen, Zhonghua, Zhang, Bo, Wu, Zhouliang, Tian, Dawei, Hu, Hailong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915098/
https://www.ncbi.nlm.nih.gov/pubmed/29719631
http://dx.doi.org/10.18632/oncotarget.23896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915098/
https://www.ncbi.nlm.nih.gov/pubmed/29719631
http://dx.doi.org/10.18632/oncotarget.23896

Ejemplares similares